BioCardia BCDA
NASDAQ BCDA
$1.01 -0.02 (-1.92%)
As of: Sep 30, 2026 · 3:56 PM EDT

BioCardia (BCDA) Short term Debt (2010 - 2015)

Updated

BioCardia's Short term Debt was $5.67 million in Q4 2015.

Analysis

BioCardia (BCDA) Short term Debt (2010 - 2015) Analysis & Trends

  • Short term Debt shows a five-year compound annual growth rate of 95.2% (FY2010 to FY2015).
  • The Q4 2015 figure marks the lowest quarterly Short term Debt since Q4 2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 BioCardia 12.46 Mn -407,934.31 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 5.67 Mn
Dec 31, 2010 200,000.00
API Access

BioCardia Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=BCDA&period=max&api_key=YOUR_API_KEY